1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E9797246F05FAF6F8525704400768084
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-ensuring-drug-safety-tactics-to-safeguard-brands?opendocument
18
19opendocument
2034.237.76.91
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing Marketing Management Deploying Marketing Programs Brand Management

Ensuring Drug Security: Effective Tactics To Safeguard Brands

DB Image

ID: 4825


Features:

Metrics, Graphics, Detailed Process Map


Pages/Slides: 66


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • SPECIAL OFFER
This 66-slide presentation examines how companies organize Brand Security functions to safeguard against unauthorized parallel imports and counterfeit products across business units and geographies. Pharmaceutical, biotech and manufacturing companies can benefit from this presentation as it details operational tactics to safeguard brands, as well as potential pitfalls to those tactics.

Industries Profiled:
Biotech; Manufacturing; Pharmaceutical; Health Care; Medical Device


Companies Profiled:
Allergan; NOSCO Printing Group; Purdue Pharma; Novo Nordisk; Schering-Plough; Roche; Takeda Pharmaceuticals; Guidant

Study Snapshot

This document is the result of a Best Practices, LLC project for a pharmaceutical Business Excellence Board client. It is based on the survey responses of 11 leading benchmark partners in the pharmaceutical, biotech and manufacturing industries.

Key topics include:

  • Key Findings
  • Operational Tactics to Safeguard brands
  • Structure, Staff and Resource Investment in the Brand Security Function
  • Brand Security Processes and Procedures
  • Top Lessons Learned

Sample Key Findings

The supply chain rates as an area of key concern for most pharmaceutical companies. Those companies that can deal with potential problems at the supply chain level are better positioned to control brand security.
  • Tamper-evident packaging is seen as one of the best manufacturing approaches to safeguard pharmaceutical products as 91% find it to be an effective tactic. Ongoing expense and regulatory concerns were the most frequently cited implementation elements to be managed for this tactic.

Below are two examples of safeguards that proved to be useful to many companies:
  • Trademark Safeguards: Trademark and name differentiation are the highest rated safeguards on this brand security front.
  • Regulatory Safeguards: Proper labeling showing that the drug adheres to manufacturing standards is the preferred regulatory safeguard.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.